Green Park & Golf Ventures — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Prolocorprolocor.cominAug 2022
Prolocor is developing diagnostic tests related to atherosclerotic cardiovascular disease and thrombotic risk, including platelet FcγRIIa-based assessment of risk in cancer patients.
BiotechDigital HealthHealthtechMedical DevicesPhiladelphia, US
Peter M. DiBattiste(Co-founder & CEO)inDavid J. Schneider(Co-founder & CSO)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.